Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012, Article ID 541353, 11 pages
http://dx.doi.org/10.1155/2012/541353
Research Article

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer

Department of Research and Development, GenomeDx Biosciences Inc., Vancouver, BC, Canada V6J 1J8

Received 1 June 2012; Accepted 30 June 2012

Academic Editor: Anirban P. Mitra

Copyright © 2012 Nicholas Erho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Rajan, D. J. Elliott, C. N. Robson, and H. Y. Leung, “Alternative splicing and biological heterogeneity in prostate cancer,” Nature Reviews Urology, vol. 6, no. 8, pp. 454–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Pajares, T. Ezponda, R. Catena, A. Calvo, R. Pio, and L. M. Montuenga, “Alternative splicing: an emerging topic in molecular and clinical oncology,” Lancet Oncology, vol. 8, no. 4, pp. 349–357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. L. H. Boise, M. Gonzalez-Garcia, C. E. Postema et al., “bcl-x, A bcl-2-related gene that functions as a dominant regulator of apoptotic cell death,” Cell, vol. 74, no. 4, pp. 597–608, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. S. C. Chan, Y. Li, and S. M. Dehm, “Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal,” Journal of Biological Chemistry, vol. 287, no. 23, pp. 19736–19749, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Hu, W. B. Isaacs, and J. Luo, “A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities,” Prostate, vol. 71, pp. 1656–1667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Li, T. H. Hwang, L. A. Oseth et al., “AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression,” Oncogene. In press. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Chudova, J. I. Wilde, E. T. Wang et al., “Molecular classification of thyroid nodules using high-dimensionality genomic data,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5296–5304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. S. Hall, H. S. Leong, L. S. C. Armenoult et al., “Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples,” British Journal of Cancer, vol. 104, no. 6, pp. 971–981, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. B. S. Taylor, N. Schultz, H. Hieronymus et al., “Integrative genomic profiling of human prostate cancer,” Cancer Cell, vol. 18, no. 1, pp. 11–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. I. A. Vergara, N. Erho, T. J. Triche et al., “Genomic “Dark Matter” in Prostate cancer: exploring the clinical utility of ncRNA as biomarkers,” Frontiers in genetics, vol. 3, p. 23, 2012. View at Google Scholar
  11. M. N. McCall, B. M. Bolstad, and R. A. Irizarry, “Frozen robust multiarray analysis (fRMA),” Biostatistics, vol. 11, no. 2, pp. 242–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. N. McCall and R. A. Irizarry, “Thawing frozen robust multi-array analysis (fRMA),” BMC Bioinformatics, vol. 12, article 369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Yates, “xmapcore: core access to the xmap database,” 2010, http://xmap.picr.man.ac.uk.
  14. T. Nakagawa, T. M. Kollmeyer, B. W. Morlan et al., “A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy,” PLoS ONE, vol. 3, no. 5, Article ID e2318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Jiang, Y. Ma, C. Chen et al., “Androgen-responsive gene database: integrated knowledge on androgen-responsive genes,” Molecular Endocrinology, vol. 23, no. 11, pp. 1927–1933, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Y. Cho, K. Choi, J. H. Jeon et al., “Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer,” Experimental and Molecular Medicine, vol. 42, no. 4, pp. 310–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. I. B. Quintero, C. L. Araujo, A. E. Pulkka et al., “Prostatic acid phosphatase is not a prostate specific target,” Cancer Research, vol. 67, no. 14, pp. 6549–6554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. K. S. Korkmaz, C. Elbi, C. G. Korkmaz, M. Loda, G. L. Hager, and F. Saatcioglu, “Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer,” Journal of Biological Chemistry, vol. 277, no. 39, pp. 36689–36696, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Wang, Y. Jin, Y. J. Arnoldussen et al., “STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer,” Cancer Research, vol. 70, no. 14, pp. 5818–5828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Lin, J. T. White, C. Ferguson et al., “PART-I: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12,” Cancer Research, vol. 60, no. 4, pp. 858–863, 2000. View at Google Scholar · View at Scopus
  21. T. Ribarska, K.-M. Bastian, A. Koch, and W. A. Schulz, “Specific changes in the expression of imprinted genes in prostate cancer—implications for cancer progression and epigenetic regulation,” Asian Journal of Andrology, vol. 14, no. 3, pp. 436–450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. B. Meyer, A. T. Maia, M. O'Reilly et al., “A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression,” PLoS Genetics, vol. 7, no. 7, Article ID e1002165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Skaletsky, T. Kuroda-Kawaguchl, P. J. Minx et al., “The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes,” Nature, vol. 423, no. 6942, pp. 825–837, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Berretta and P. Moscato, “Cancer biomarker discovery: the entropic hallmark,” PLoS ONE, vol. 5, no. 8, Article ID e12262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. K. Nam, W. W. Zhang, D. A. Loblaw et al., “A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer,” Prostate Cancer and Prostatic Diseases, vol. 11, no. 3, pp. 241–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Robbins, W. A. Tembe, A. Baker et al., “Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors,” Genome Research, vol. 21, no. 1, pp. 47–55, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. V. K. Dasari, R. Z. Goharderakhshan, G. Perinchery et al., “Expression analysis of Y chromosome genes in human prostate cancer,” Journal of Urology, vol. 165, no. 4, pp. 1335–1341, 2001. View at Google Scholar · View at Scopus
  28. B. Naimi, A. Latil, G. Fournier, P. Mangin, O. Cussenot, and P. Berthon, “Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate,” Prostate, vol. 52, no. 3, pp. 245–252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Kapranov, G. St Laurent, T. Raz et al., “The majority of total nuclear-encoded non-ribosomal RNA in a human cell is “dark matter” un-annotated RNA,” BMC Biology, vol. 8, article 149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Wang, M. K. Hasan, E. Alvarado, H. Yuan, H. Wu, and W. Y. Chen, “NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response,” Oncogene, vol. 30, no. 8, pp. 907–921, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Bu, S. Bormann, G. Schäfer et al., “The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection,” Prostate, vol. 71, no. 6, pp. 575–587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Thorsen, K. D. Sørensen, A. Brems-Eskildsen et al., “Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis,” Molecular and Cellular Proteomics, vol. 7, no. 7, pp. 1214–1224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. P. Yu, D. Landsittel, L. Jing et al., “Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy,” Journal of Clinical Oncology, vol. 22, no. 14, pp. 2790–2799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Zhang, Y. Dong, H. Zhao et al., “Microarray data mining for potential selenium targets in chemoprevention of prostate cancer,” Cancer Genomics and Proteomics, vol. 2, no. 2, pp. 97–113, 2005. View at Google Scholar · View at Scopus
  35. T. Kanamori, K. Takakura, M. Mandai et al., “PEP-19 overexpression in human uterine leiomyoma,” Molecular Human Reproduction, vol. 9, no. 11, pp. 709–717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. M. W. Kattan, T. M. Wheeler, and P. T. Scardino, “Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer,” Journal of Clinical Oncology, vol. 17, no. 5, pp. 1499–1507, 1999. View at Google Scholar · View at Scopus
  37. J. R. Prensner, M. K. Iyer, O. A. Balbin et al., “Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression,” Nature Biotechnology, vol. 29, no. 8, pp. 742–749, 2011. View at Publisher · View at Google Scholar · View at Scopus